NewLink Genetics Corp (NLNK)

20.65
0.40 1.98
NASDAQ : Health Care
Prev Close 20.25
Open 20.30
Day Low/High 20.30 / 20.66
52 Wk Low/High 9.23 / 56.16
Volume 1.71K
Avg Volume 334.10K
Exchange NASDAQ
Shares Outstanding 29.22M
Market Cap 603.32M
EPS -2.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

NewLink Genetics Provides Operational & Clinical Update, Reports Fourth Quarter, Year-End 2016 Financial Results

NewLink Genetics Provides Operational & Clinical Update, Reports Fourth Quarter, Year-End 2016 Financial Results

Management to Host Conference Call and Webcast Today at 8:30 a.m. ET

Notable Monday Option Activity: NLNK, WTW, EBIX

Notable Monday Option Activity: NLNK, WTW, EBIX

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in NewLink Genetics Corp , where a total volume of 1,845 contracts has been traded thus far today, a contract volume which is representative of approximately 184,500 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 68.5% of NLNK's average daily trading volume over the past month, of 269,305 shares.

Newman Ferrara LLP Announces Corporate Governance Investigation Of NewLink Genetics Corporation

Newman Ferrara LLP Announces Corporate Governance Investigation Of NewLink Genetics Corporation

Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of NewLink Genetics Corporation ("NewLink" or the "Company") (NASDAQ:NLNK) into potential breaches of fiduciary duty...

Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference

Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference

The $5.2 billion takeout of Ariad Pharma was the biggest news from the closely followed healthcare conference.

Notable Monday Option Activity: NLNK, MSM, EXAS

Notable Monday Option Activity: NLNK, MSM, EXAS

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in NewLink Genetics Corp , where a total volume of 1,779 contracts has been traded thus far today, a contract volume which is representative of approximately 177,900 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 71.4% of NLNK's average daily trading volume over the past month, of 249,020 shares.

Stock Picks Are Hard to Find as Small-Caps Struggle

Stock Picks Are Hard to Find as Small-Caps Struggle

With poor breadth and money managers hiding in large-caps, I am being cautious, right now.

Biotech Stocks Surge Monday Amid Flurry of Deal Activity

Biotech Stocks Surge Monday Amid Flurry of Deal Activity

Deals, though, weren't the only mover of share prices.

Shark Bites: We Knew Today Would Be Slow, but Come On…

Shark Bites: We Knew Today Would Be Slow, but Come On…

Don't force it; there's no energy.

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

Commit To Buy NewLink Genetics Corp At $8, Earn 16.2% Using Options

Commit To Buy NewLink Genetics Corp At $8, Earn 16.2% Using Options

Investors considering a purchase of NewLink Genetics Corp stock, but tentative about paying the going market price of $10.90/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2018 put at the $8 strike, which has a bid at the time of this writing of $1.30.

NewLink Genetics Becomes Oversold (NLNK)

NewLink Genetics Becomes Oversold (NLNK)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive

Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive

The imbalances in patient baseline characteristics provided an assist to Corbus' resunab treatment response and undermines the credibility of the trial results, a source says.

NewLink Genetics Corporation Provides Operational Update And Reports Third Quarter 2016 Financial Results

NewLink Genetics Corporation Provides Operational Update And Reports Third Quarter 2016 Financial Results

Management to Host Conference Call Today at 8:30 a.m. ET

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving NewLink Genetics Corporation And A Lead Plaintiff Deadline Of July 11, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving NewLink Genetics Corporation And A Lead Plaintiff Deadline Of July 11, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased NewLink Genetics Corporation (NASDAQ:NLNK)...

INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving NewLink Genetics Corporation And A Lead Plaintiff Deadline Of July 11, 2016

INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving NewLink Genetics Corporation And A Lead Plaintiff Deadline Of July 11, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased NewLink Genetics Corporation (NASDAQ:NLNK)...